Physician profile
Junior Espinal
NPI 1356929863
$296.19
in general payments reported to CMS, 2019-2025
6 companies · $80.46 in 2025
The $80.46 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.08 · 2022: $12.95 · 2023: $29.91 · 2024: $131 · 2025: $80.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $157.19 | 2021-2024 | Repatha |
| Recor Medical INC | $55.46 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic, INC. | $28.63 | 2021 | |
| Mannkind Corporation | $25.00 | 2025 | |
| Glaxosmithkline, LLC. | $16.63 | 2023 | Shingrix |
| Inspire Medical Systems, INC. | $13.28 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junior Espinal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.